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Background: Deep brain stimulation (DBS) is an effective treatment for reducing symp-
toms of tremor. A common and typically subjectively determined adverse effect of DBS is 
dysarthria. Current assessment protocols are driven by the qualitative judgments of treating 
clinicians and lack the sensitivity and objectivity required to optimize patient outcomes 
where multiple stimulation parameters are trialed.
Objective: To examine the effect of DBS on speech in patients receiving stimulation 
to the posterior sub-thalamic area (PSA) via randomized manipulation of amplitude 
parameters.
Methods: Six patients diagnosed with tremor receiving treatment via DBS of the PSA 
were assessed in a double-blinded, within-subjects experimental protocol. Amplitude (i.e., 
voltage or current) was randomly adjusted across 10 settings, while speech samples (e.g., 
sustained vowel, counting to 10) were recorded to identify the patient-specific settings 
required for optimal therapeutic benefit (reduced tremor) with minimal adverse effects 
(altered speech). Speech production between stimulation parameters was quantified 
using acoustic analysis.
results: Speech changed as a response to DBS but those changes were not uniform 
across patients nor were they generally in line with changes in amplitude with the exception 
of reduced vocal control and increased mean silence length in two patients. Speech 
outcomes did not correlate with changes in tremor.
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introduction
Deep brain stimulation (DBS) is well established as a safe and 
effective treatment option for reducing tremor severity where drug 
therapy is ineffective (Plaha et al., 2004; Blomstedt et al., 2010). 
Aside from perioperative complications (e.g., intra-cranial hemor-
rhage) (Hariz, 2002) and hardware-related problems (e.g., electrode 
misplacements, infections, and device malfunction) (Carvallo et al., 
2011), two issues relating to stimulation and optimization inhibit 
the utility of the technique. First, the possible combinations of 
stimulus parameter settings are too great for clinical-based explora-
tion in individuals, often leading to the use of default parameters. 
Second, a common and typically unquantified (i.e., assessed 
subjectively) adverse effect of DBS is dysarthria (neuromuscular 
speech disorder) (Skodda et al., 2011; Tripoliti et al., 2011).
The efficacy of DBS is partly dependent on the capacity of clini-
cians to determine optimal stimulation settings. Yet, qualitative 
assessment protocols do not allow for precise comparison between 
the effects of stimulus parameter settings. They also limit the capac-
ity of clinicians to evaluate the comparative influence of tremor and 
speech effects when determining a clinical endpoint. Historically, 
empirical investigations of speech production in DBS have utilized 
perceptual assessment practices, where a clinician listens to the 
speech of a patient in order to judge its quality (Murata et al., 2003; 
Plaha et al., 2004; Farrell et al., 2005). However, the limitations of 
subjective evaluation of speech (i.e., bias and error) are well known 
(Kent, 1996), including limited capacity of listeners to determine 
the size of change from one production to the next, the influ-
ence of experience on the capacity of a listener to identify (and 
quantify) changes in speech, and the limited inter- and intra-rater 
reliability of auditory-perceptual judgment (Vogel and Maruff, 
2014). An objective alternative to listener-based observation is 
acoustic analysis of speech, which provides objective measurement 
of speech output through the study of the physical properties of 
the speech signal. By quantifying changes in speech that may be 
associated with DBS, the clinician/researcher is able to determine 
the size and nature of any side-effects alongside the desired primary 
outcome of tremor reduction.
Speech does not occur in all patients receiving DBS. In patients 
with essential tremor receiving DBS, reports of stimulation-induced 
dysarthria occur in 10% of cases (Flora et al., 2010). Perhaps more 
importantly, changes in speech that can occur following DBS are 
highly variable (Xie et al., 2012). Speech outcomes appear to differ 
depending on site of stimulation, etiology of disorder, site of lesion, 
severity of tremor, and methods used to measure speech production 
(Deuschl et al., 2006; Tripoliti et al., 2008). Documented changes to 
speech after DBS include, but are not limited to, increases in voice 
onset time and decreased rate of speech (Barbe et al., 2014), inappro-
priate voicing (Karlsson et al., 2012), decreased maximum phonation 
time (Pinto et al., 2014), longer maximum phonation time and faster 
rate of speech (Gentil et al., 2003), reduced intelligibility (Törnqvist 
et al., 2005; Tripoliti et al., 2008; Åström et al., 2010; Pinto et al., 
2014), and improved vocal quality and control (D’Alatri et al., 2008).
Few studies have combined objective measures of speech and 
systematic modification of DBS stimulus settings. Where objec-
tive (acoustic) measures were used, the majority of studies have 
evaluated the effect of DBS via an ON/OFF stimulation protocol 
(Gentil et al., 2003; Van Lancker Sidtis et al., 2010; Karlsson et al., 
2012). Where researchers have altered DBS electrical parameters 
beyond a simple on/off paradigm, most have utilized perceptual 
(subjective) assessments of speech (Törnqvist et al., 2005; Tripoliti 
et al., 2008; Åström et al., 2010). A recent study, which investigated 
the therapeutic benefit of differentially stimulating two contacts on 
the same electrode with the aim of reducing stimulation-induced 
dysarthria, used a combination of acoustic, patient self-report, and 
listener ratings to measure changes in speech (Barbe et al., 2014). 
These authors appear to be the first to have published data on 
systematically modifying DBS settings for the purpose of alleviat-
ing dysarthria. Through the use of voice onset time (objective) 
and patient-completed visual analog scales (subjective), their 
study showed that dysarthric side effects can be reduced using 
individualized current shaping on two active DBS electrodes. 
Their proof of principle study demonstrated the potential value of 
adjusting stimulation parameters for individual patients, although 
it was limited by the use of only one objective measure of speech.
In the experiments reported below, we objectively tracked 
changes in speech resulting from randomly altered stimulus 
amplitude in patients with tremor (either essential, cerebellar 
intention, or dystonic tremor types) receiving stimulation to the 
posterior sub-thalamic area (PSA). Patients and experimenters 
assessing speech were blinded to stimulus settings. The protocol 
aimed to capture changes in speech resulting from altered stimulus 
amplitude using a protocol proven to be stable and sensitive for 
monitoring change over time. We aimed to identify patient-specific 
settings that resulted in optimal therapeutic benefit (reduced 
tremor) with minimal adverse effects (altered speech). Given 
the heterogeneity of speech outcomes from earlier work, it was 
hypothesized that the optimal stimulus level for tremor suppres-
sion would not correspond to optimal speech outcomes.
Patients and Methods
Six adults diagnosed with essential tremor, cerebellar intention 
tremor, or dystonic tremor and receiving treatment via DBS of 
the PSA were recruited from a neurology clinic in Melbourne, 
VIC, Australia. Demographic and implant information is 
provided in Table 1. Patients were included in the study if they 
presented with a confirmed diagnosis of tremor, had undergone 
conclusion: Intra-individual changes in speech were detected as a response to modified 
amplitude; however, no clear pattern was observed across patients as a group. The use 
of objective acoustic measures allows for quantification of speech changes during DBS 
optimization protocols, even when those changes are subtle and potentially difficult to 
detect perceptually.
Keywords: side effects, optimization, dysarthria, acoustic analysis, speech, brain stimulation
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DBS surgery with bilateral stimulation of the PSA, were aged 
between 18 and 80 years, and had English as their first language. 
Patients were excluded if they reported speech impairment prior 
to the onset of tremor or DBS treatment. Approval to conduct 
this study was obtained from the Royal Melbourne Hospital 
Ethics Committee. Written informed consent for research was 
obtained from all patients participating in the study.
surgery
Preoperative MRI and stereotactic CT images were fused using 
the StealthStation Surgical Navigation System (Medtronic, 
Minneapolis, MN, USA) to plan lead trajectory. Target coordi-
nates for the PSA were determined as a point 2–3 mm lateral 
to the equator of the red nucleus, halfway to the sub-thalamic 
nucleus, 4–6  mm below the intercommissural plane. The tra-
jectory was planned to avoid vessels, sulci, and ventricles. We 
performed intraoperative microrecording and microstimulation 
(Leadpoint-system, Medtronic) to verify the target coordinates, 
and the most-ventral contact of the DBS lead was positioned at 
this point. Table 1 lists the neurostimulator and lead types for each 
patient. All patients were implanted bilaterally. Following surgery, 
electrode placement was verified by an independent neurosurgeon 
using postoperative CT fused with the preoperative MRI.
Procedure
A double-blinded, within-subjects experimental design was 
employed. Patients and assessors were blinded to the stimulation 
condition. Electrical stimulation parameters (i.e., voltage or cur-
rent levels) were systematically adjusted following a random order 
of testing over the course of one session. Stimulation parameters 
were switched after speech and movement tasks were completed.
TaBle 1 | Participant demographic and implant information.

























1 ET M 72 4 18 St Judes Brio 
ActiveTip 3 mm leadsa
Bilateral 90 130 2.5 (bilateral) 0.0, 0.75, 1.5, 
2.2, 3.0, 3.5, 4.0
2 ET F 48 17 20 Medtronic activa RC 
model 3387b





F 71 15 35 St Jude Libra 
ActiveTip 3 mm leadsa
Bilateral 90 130 1.4 (L),  
0.6 (R)




F 47 6 25 Medtronic activa RC 
model 3387b
Bilateral 90 130 3.5 (L),  
2.3 (R)
0.0, 1.5, 1.8, 2.1, 
2.4, 2.7, 3.0
5 ET M 56 16 18 Medtronic activa RC 
model 3387b
Bilateral 90 130 2.4 (L),  
3.3 (R)
3.3, 3.8, 4.4, 5.0, 
5.4, 5.8d
6 ET F 44 15 30 Medtronic activa RC 
model 3387b
Bilateral 60 150 2.3 (bilateral) 0.0, 1.5, 1.9, 2.4, 
3.0, 3.6, 4.3
aDevice measured in milliamps.
bDevice measured in volts.
cPulse duration and frequency set to 90 and 130, respectively, for all patients and conditions.
dParticipant became emotionally labile when lower voltages were attempted.
ET, essential tremor; L, left; R, right; Hz, Hertz; mA, milliamps; M, male; F, female.
Patient 6 treated with clonazepam 0.5 mg/day in addition to DBS. All patients implanted bilaterally.
stimulus amplitude Manipulation
The clinically set values of the stimulation parameters (determined 
on a previous visit by the consultant neurologist and specialist 
nurse) were used as reference values around which stimulation 
variations were made (see Table 1). The Medtronic devices used 
by a subset of these subjects control the level of stimulus amplitude 
using voltage, whereas the St Jude devices use current. Here, 
we have described both voltage and current as amplitude. The 
stimulator controlling the most-affected side was adjusted first, 
while the second side was turned off. Keeping reference values of 
frequency (130 Hz) and pulse duration (90 μs) fixed, amplitude was 
manipulated so that the levels at which tremor suppression began 
(threshold) and side effects (e.g., general tingling sensations, visual 
disturbances beyond typical function, emotional lability) began 
to appear, were established using patient feedback and clinical 
observation. A series of amplitude steps between threshold and 
side-effect onset were then selected for use in the assessments, in 
addition to the device-off condition. For example, where the tremor 
suppression threshold was 0.75 V, and side-effect onset was 4 V, the 
series of voltage steps was (0.0, 0.75, 1.5, 2.2, 3.0, 3.5, and 4.0 V). 
The amplitude steps were presented in random order. No data were 
collected in the first minute following each parameter adjustment 
to facilitate adaptation to the new value. After this period, both 
tremor and speech assessments were administered. Following 
the measures with unilateral stimulation, the first-side amplitude 
was fixed at the clinically observed optimal amplitude for tremor 
suppression, and the second device turned on. The threshold for 
tremor suppression and side effect were then established for the 
second side (while leaving the first-side on) and three amplitudes 
were selected that spanned the range between threshold and side 
effect. The same tremor and speech measures were obtained for 
these three bilateral conditions.
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Patient evaluation
Tremor
During the tremor examination, patients were required to per-
form two manual tasks in order to assess postural and kinetic 
tremors. Tasks included sustained bilateral arm extension, and 
a bilateral finger–nose–finger maneuver with each arm (Elble 
et al., 2012) (while verbally counting to 10). Tremor severity was 
assessed during these tasks on a scale of 0–10 through consensus 
rating by the consultant neurologist and a specialist nurse. Each 
limb was assessed separately, and the two scores averaged for 
data analysis.
Speech Analyses
Speech samples were acquired using a standard laptop PC coupled 
with an external sound card (model UA-25, Roland Corporation, 
Shizuoka, Japan) and an AKG 520C condenser microphone 
(AKG Acoustics GmbH, Vienna, Austria). Patients performed 
three speech production tasks in each condition: (i) producing 
a sustained vowel /a:/ for 6 s; (ii) counting from 1 to 10; and (iii) 
reading a phonetically balanced paragraph, the “Grandfather 
passage” (Van Riper, 1963). Patients were asked to practice the 
tasks once before recording commenced to reduce unfamiliarity 
effects often observed in repeated trials with brief inter-recording 
intervals (Vogel et al., 2011; Vogel and Maruff, 2014).
Quantitative data were extracted from the sound recordings 
using automated scripts written for use with freely available 
software, Praat (Boersma, 2001), to generate measures of timing, 
vocal control, and voice quality. Measures of timing were obtained 
from recordings of speech produced in the counting and reading 
tasks, and included speech rate (SRATE, syllables/second), mean 
silence time (SMEAN, seconds), variability of silence length 
(VSIL, seconds), and percentage of silence in a sample (PSIL). 
Timing measures were automatically calculated using methods 
designed to identify “silences” within a speech sample based on 
the intensity contour using a modified version of techniques 
described by Rosen et al. (2010) and implemented by Vogel et al. 
(2012, 2014). Three thresholds were defined to identify silences 
from the intensity contour: (a) Intensity threshold, (b) minimum 
silence duration (15 ms), and (c) minimum speech duration (30 ms). 
Silence segments were defined as the parts of the intensity contour 
that fell below the intensity threshold. Silence sections that were 
shorter than 15  ms were classed as speech and concatenated 
with the adjacent speech sections. Speech sections that were 
shorter than 30  ms were classed as silences and concatenated 
with the adjacent silences. The intensity threshold was set to 0.65 
of the distance between the reference intensity (equal to 0.95 of 
the maximum intensity) and floor intensity (minimum). Reference 
intensity selection of 0.95 of the maximum intensity has been 
found more robust than use of the maximum, median, or modal 
intensities due to irregular bursts of energy that often occur with 
sporadically loud syllables or short phrases in spontaneous speech 
(e.g., emphatic stress). Visual inspection of the spectrum has 
shown that 0.95 of the maximum intensity represents the typical 
intensity of syllable peaks, whereas maximum intensity reflects a 
single observation interval and is less reliable than use of the refer-
ence intensity threshold described. The timing measures derived 
from this method included total silence time, total speech time, 
the percentage of silence in the sample, and speech rate (number 
of syllables/total signal time).
Fundamental frequency (f0) and coefficient of variability (CoVs) 
were derived from the sustained vowel task using an automated 
PRAAT script (Vogel et  al., 2009). f0 calculations are made in 
PRAAT by employing a user-supplied estimate of the window 
length for acoustic analysis. To determine window length, two 
primary program parameters are taken into consideration: time 
step and pitch floor. Time step is a measurement interval (frame 
duration) parameter measured in seconds, and is calculated by 
dividing 0.75 by the Pitch floor. For example, if the Pitch floor is 
set to 75 Hz, then the Time step equals 0.01 s (0.75/75), specifying 
100 pitch values to be computed by PRAAT per second. Pitch floor 
is used to specify the length of the acoustic analysis window, and 
also represents the lowest fundamental frequency (f0) that can be 
measured within each speech sample. To accurately calculate pitch, 
the analysis window must be long enough to detect three periods 
of the pitch frequency to be identified. For example, in order to 
identify a Pitch floor of 75 Hz, the effective analysis window will 
be 3/75, or 0.04 s long. Increasing the Time step will speed up the 
editor window; however, it can lead to under sampling of the pitch 
and formant curves, which could influence the accuracy of the 
selected acoustic measures. Pitch ceiling is a program parameter 
used at the post-processing stage to ignore candidates above the 
prescribed setting based on prior research and experience. This 
process promotes the most efficient use of available data and is 
based on empirical findings detailed in Vogel et al. (2009), which 
demonstrated the reliability and validity of the described methods. 
Data provided in this report calculated f0 using generic window 
lengths to expedite batch processing of the speech samples for 
both male and female populations. Pitch range settings for males 
encompassed low Pitch floors (70 Hz) and a mid-level Pitch ceiling 
(250 Hz). Pitch floor settings of 100 Hz and ceiling setting of 300 Hz 
were used for female speakers.
Voice quality was determined using harmonics-to-noise ratio 
(HNR) derived from Praat. The sustained vowel task was chosen 
to evaluate voice quality and control as it provides better classifica-
tion of disordered voicing compared to connected speech samples 
(Parsa and Jamieson, 2001). The focus on measures of timing and 
laryngeal control was designed to provide a proxy of overall dysar-
thria severity using easily acquired objective measures of speech. 
These measures have demonstrated the sensitivity to change and 
impairment in both healthy and pathological groups (e.g., fatigue, 
noise, hereditary ataxia, Huntington’s disease) (Vogel and Maruff, 
2008; Vogel et al., 2010, 2011, 2012, 2014; Mundt et al., 2012; Yiu 
et al., 2015). Importantly, the stability of the chosen measures has 
been established in a series of within-subjects experiments over 
short-, medium-, and long-term inter-recording intervals (Vogel 
et al., 2011; Vogel and Maruff, 2014).
Overall improvements in speech were determined via higher 
values of HNR (improved voice quality), lower values of f0 CoV 
(improved vocal control), and the following measures of timing 
efficiency and control: lower mean silence length, increased speech 
rate, reduced silence length variability, and decreased percent 
silence. Reduced mean silence length can indicate more natural 
sounding speech, because, as a speaker transitions from one 
phonemic element to the next, they are able to continue voicing 
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with shorter breaks. Decreased mean silence length combined with 
reduced silence length variability and decreased percent silence 
result in increased speech rate and overall improved efficiency 
(Yiu et al., 2015).
results
Five of the six patients completed speech/movement tasks at 
all stimulus amplitudes. Patient 5 did not tolerate reduction of 
stimulation, completing 9/10 experimental conditions. P5 did not 
have a clinical baseline measured, as she commenced the protocol 
with one of her devices turned off. Figures 1 and 2 show the effects 
of unilateral current or voltage manipulation on tremor severity 
and speech timing measures for the reading and counting tasks, 
respectively. Figure 3 shows the voice quality and control measures 
along with the same tremor measures as Figures 1 and 2. Data on 
baseline performance are also displayed to provide comparative 
information on the effects of stimulation. Data indicate the effect of 
stimulus amplitude on tremor severity and speech quality differed 
among subjects (Figures 1–3).
response to DBs: Tremor
Where data were broken down into three classes (Off stimulation; 
Maximum amplitude; Amplitude threshold – where tremor sup-
pression begun), one-tailed t-tests showed that tremor severity 
was significantly reduced for stimulus amplitudes at the side-effect 
threshold (t = 5.477, p = 0.003) and the tremor suppression thresh-
old (t = 2.557, p = 0.03), compared to the device-off condition. 
There was no significant difference between tremor at the tremor 
suppression threshold and the side-effect threshold (t =  1.348, 
p = 0.12). Two-tailed paired t-tests comparing speech measures 
at the same three unilateral stimulus amplitudes did not show any 
significant group effects of stimulus amplitude (p > 0.05).
In each case [except Patient 5 (P5) where data were not 
available], tremor severity decreased with introduction of DBS 
(comparing the device-off condition, with the optimum bilateral 
FigUre 1 | speech and tremor data during the reading passage. Closed 
circles, tremor severity; open circles, speech timing measures; in the left 
shaded area of each panel are the clinical baseline tremor ratings (up closed 
triangle), the best tremor rating obtained in the study (down closed triangle). 
Both baseline and best performance ratings were obtained with bilateral 
stimulation, along with the corresponding speech scores for the same 
conditions (up open triangle for clinical baseline and down closed triangle for 
best performance). For all measures, values closer to the x-axis were 
considered an improvement. r values reflect correlation between speech and 
tremor.
FigUre 3 | speech and tremor data during the sustained vowel task. 
Closed circles, tremor severity; open circles, voice quality and control 
measures; in the left shaded area of each panel are the clinical baseline tremor 
ratings (up closed triangle), the best tremor rating obtained in the study (down 
closed triangle). Both baseline and best performance ratings were obtained 
with bilateral stimulation, along with the corresponding speech scores for the 
same conditions (up open triangle for clinical baseline and down closed triangle 
for best performance). Note that the HNR scale is reversed to show 
improvements in performance reflected in decreased values on the figure. r 
values reflect correlation between speech and tremor.
FigUre 2 | speech and tremor data during the counting task. Closed 
circles, tremor severity; open circles, speech timing measures; in the left 
shaded area of each panel are the clinical baseline tremor ratings (up closed 
triangle), the best tremor rating obtained in the study (down closed triangle). 
Both baseline and best performance ratings were obtained with bilateral 
stimulation, along with the corresponding speech scores for the same 
conditions (up open triangle for clinical baseline and down closed triangle for 
best performance). For all measures, values closer to the x-axis were 
considered an improvement. r values reflect correlation between speech and 
tremor.
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condition of the study, as illustrated by closed down-triangles in 
Figures 1–3). For all subjects except P5, the optimal experimental 
tremor reduction was equal to or better than the clinical baseline 
tremor reduction (comparing the down and up closed triangles). 
In two cases (P2 and P6), the clinical baseline measure showed 
worse or similar tremor to the “off ” condition.
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correlation Between amplitude, Tremor, speech, 
and Voice Measures
Pooling data from all patients revealed no significant correla-
tions between tremor and speech/voice measures. Covariance 
of acoustic measures from all patients revealed strong and 
significant relationships between SMEAN and VSIL (ρ = 0.915, 
p < 0.001), PSIL (ρ = 0.828, p < 0.001) and speech rate (ρ = 0.81, 
p < 0.001), as well as speech rate and VSIL (ρ = 0.845, p < 0.001) 
on the counting task. Weak but significant relationships were 
observed between f0 CoV and all timing measures derived 
from the counting task (ρ > 0.45, p < 0.001). Similarly, weak 
but significant correlations were observed between speech rate 
derived from the reading task and all other speech metrics 
(ρ = 0.42–0.46, p < 0.001) (with the exception of HNR, which 
was not significant). HNR co-varied with f0 CoV on the sustained 
vowel task (ρ = −0.39, p = 0.002) and PSIL on the counting task 
(ρ = −0.46, p < 0.001).
Given the heterogeneity of the data between subjects and 
speech measures, and the difference in amplitude units, only 
within-subject correlations were performed to test the relation 
between amplitude, tremor, and speech measures. The correla-
tions for speech/voice and tremor used both the unilateral and 
bilateral stimulation conditions and are shown in Figures 1–3. 
Only data from P2 yielded significant correlations between tremor 
and speech measures; tremor rating was positively correlated with 
voice quality and control measures (Figure 3), and two of the four 
speech timing measures in the counting task (Figure 2). Significant 
correlations were observed between amplitude and vocal control 
(f0 CoV) for P1 (ρ = −0.637, p = 0.035) and P4 (ρ = 0.8, p = 0.003) 
and speech timing [P3: SMEAN (reading) ρ = 0.883, p = 0.008; P5: 
speech rate (counting) ρ = 0.783, p = 0.013; P6: SMEAN (counting) 
ρ = −0.648, p = 0.031 and PSIL (counting) ρ = −0.653, p = 0.029]. 
Tremor data from P1 significantly correlated with amplitude 
(ρ = 0.934, p < 0.001). Tremor severity did not significantly cor-
relate with amplitude in P2–P6.
response to DBs: Patient-specific speech 
Outcomes
P1 showed a monotonic decline in tremor severity with increasing 
unilateral current. In contrast, P1 showed little variation in speech 
timing measures on the reading task (Figure 1), with simultane-
ous deterioration of speech timing at 2 mA on the counting task 
(Figure 2) and voice quality at 1 mA (Figure 3). For this patient, 
the optimal stimulus current range (3 mA and above) for tremor 
suppression did not produce any clear benefits or deficits in speech 
production.
P2 showed a non-monotonic effect of voltage on tremor 
suppression, with maximal tremor severity observed at 2 V and 
minimal severity at 3 V and above. Speech timing measures for the 
reading passage did not change with voltage (Figure 1); however, 
all the speech measures derived from the counting and vowel tasks 
(Figures 2 and 3) followed the same non-monotonic pattern as 
tremor severity, with the poorest speech outcomes at the same 
mid-range voltage (2 V). For this patient, DBS stimulation between 
2 and 2.5 V caused a deficit in speech production. However, for 
the stimulus amplitudes that produced the most effective tremor 
suppression, speech production was similar to the off condition.
P3 also showed a non-monotonic effect of current on tremor 
suppression, with minimum tremor seen at currents of 1, 2, and 
3  mA. Speech timing measures tended to worsen for currents 
of 4  mA and above (Figure  2). They were similar to the “off ” 
condition for currents that optimized tremor suppression. The 
vocal control measures (Figure  3) varied non-monotonically 
with current, with optimum control in the same range as currents 
producing optimal tremor suppression.
P4 showed only mild tremor suppression due to DBS stimulation, 
with limited response in speech measures aside from decreased 
variability of silence length timing at 2 V. The unilateral voltage 
range for optimal tremor suppression (2 V and above) did not 
produce any strong speech changes.
P5 showed a trend for more tremor suppression with increasing 
voltage, with optimal tremor suppression at the highest unilateral 
voltage. Speech timing measures remained relatively stable on the 
reading passage (Figure 1); however, changes were observed on 
the counting task with timing data showing a parabolic pattern 
with the greatest effect on speech detected between 4 and 5 V. 
The highest unilateral voltage, at which tremor suppression was 
optimal, produced speech scores that were equivalent to the “off ” 
condition.
P6 showed little effect of unilateral voltage adjustment, with 
optimal tremor suppression at the highest voltages (3.6 and 4.3 V) 
and at 1.5 V. Tremor was completely suppressed, however, in the 
optimal bilateral condition (downward closed triangle). Speech 
measures remained relatively stable with changes in unilateral 
voltage with the exception of speech rate on the counting task, 
which decreased in line with increased voltage (Figure 2).
In summary, the speech measures did not change consistently 
with increasing stimulus level, nor were they correlated positively 
or negatively with the tremor ratings, except for P2. In some cases, 
the stimulus amplitudes that provided optimal tremor suppression 
also produced speech scores that were very similar to the “off ” 
condition.
Discussion
This is a proof of principle study investigating the feasibility of 
using acoustic measures to quantify speech in response to multiple, 
randomized amplitude settings in patients receiving DBS for 
tremor. The preliminary nature of our study was controlled by 
blinding patients and assessors to stimulation settings; using objec-
tive measures of speech; and utilizing a speech battery designed to 
monitor change by minimizing the impact of practice, familiarity, 
and fatigue often induced by repetitive production (Vogel et al., 
2011; Vogel and Maruff, 2014).
Our data partially support the primary hypothesis that speech 
outcomes do not correlate with changes in tremor. On a patient 
by patient basis, only P2 produced speech that statistically signifi-
cantly co-varied with changes in tremor. The absence of a clear 
relationship between pitch variability and tremor (except for P2) 
was surprising given increases in pitch variability (f0 CoV) can 
result from poor laryngeal control and vocal tremor. However, 
inclusion of other markers of vocal tremor, such as intensity vari-
ation, may have provided different results (Finnegan et al., 2003). 
Speech did change as a response to DBS but those changes were 
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not uniform across patients nor were they generally in line with 
increases in amplitude with the exception of reduced vocal control 
and increased mean silence length in two patients. PSTA stimula-
tion reduced motor symptoms in the cohort. The lack of a strong 
relationship between motor and speech function suggest that PSTA 
stimulation may have dissociable effects on these functions.
In our cohort, optimal experimental tremor suppression was 
equal to or better than the baseline stimulation settings deter-
mined clinically. These data indicate that current/voltage shaping 
beyond the small stimulation range typically employed in clinical 
assessments can provide more effective symptom management 
(Miocinovic et al., 2014). Furthermore, in two cases (P2 and P6), 
tremor severity at clinical baseline was worse or similar to the 
“off ” condition, suggesting the need for more frequent updating 
of parameter settings in some individuals (Ruge et al., 2011).
Changes in a narrow range of speech measures corresponding 
to modifications in amplitude for some patients supports evidence 
that speech changes with changes in amplitude (Barbe et al., 2014). 
Three of the four timing measures and 1/2 the voice measures 
were found to co-vary with changes in amplitude: mean silence 
length (reading and counting), speech rate (counting), percent 
silence (counting), and vocal control (vowel). Taken together, these 
acoustic measures tentatively suggest a subtle but objective change 
to speech timing and control in 5/6 patients following increases in 
amplitude. Mean silence length is a measure of pauses between and 
within words, and increases in this metric can result in dysarthric-
like speech. Increases in silence length combined with an overall 
slowing of speech rate (i.e., fewer syllables produced per second) 
and increases in variation of fundamental frequency can have 
an overall detrimental effect on the prosody of speech [prosody 
in this case defined in terms of suprasegmental components of 
speech, such as duration, intensity, and f0 (Fletcher, 2010)]. That 
is, changes in rate and transitions between the spoken components 
of speech (as compared to silences between words) can reduce the 
intelligibility and naturalness of the speaker. When combined with 
altered voice quality and control, the clarity of a patient’s speech 
can be wholly undermined by changes in timing; however, vocal 
control, not voice quality, correlated with changes in amplitude or 
tremor in some patients.
Recent work exploring the role of amplitude changes and the 
induction of ataxic-like symptoms has suggested a link between 
increased stimulation below the thalamus and stimulation-induced 
ataxia (Herzog et al., 2007; Groppa et al., 2014). Ataxic dysarthria 
is associated with a slower speech rate, dysphonia (voice quality 
disturbance), reduced vocal control on sustained vowel tasks, and 
imprecise articulation (Kent et al., 2000; Folker et al., 2012), among 
other speech characteristics. Volkman and colleagues (Herzog 
et al., 2007; Groppa et al., 2014) have proposed the presence of 
ataxic symptoms may be caused by additional recruitment of 
adjacent white matter pathways when stimulation amplitudes are 
increased. Stimulation of the PSTA is known to reduce tremor 
symptoms (Murata et al., 2003; Hamel et al., 2007; Blomstedt et al., 
2010); however, the spread of stimulation beyond the target area 
may lead to ataxic movement and potentially speech disturbances, 
thus reducing the overall benefit of DBS. In the current study, 
strong and statistically significant correlations were differentially 
found between amplitude and speech timing/vocal control in 5/6 
patients. On measures of vocal control (f0 CoV), P1 had a nega-
tive correlation with amplitude, whereas P4 showed the opposite. 
Similarly, P3 produced greater mean silence lengths on the reading 
task in line with increases in amplitude, whereas P6 showed the 
opposite on the counting task. No clear relationship was found 
between voice quality and amplitude. The heterogeneous response 
of speech to amplitude and seemingly random relationship with 
tremor suppression (given that all patients responded to DBS in 
relation to tremor) highlights the need for more work on determin-
ing which clinical/neuroanatomical factors negatively influence 
speech production following DBS. In spite of the significant cor-
relations between amplitude and speech in the majority of patients, 
the range of optimal stimulus amplitudes for tremor suppression 
produced speech measures that were very similar to the device-off 
condition, suggesting that, at least in these patients, DBS stimula-
tion at clinically effective (for tremor suppression) levels did not 
lead to significant changes in speech overall.
implications
Here we present the first study to investigate the effect of randomized 
amplitude manipulation on speech production by patients using 
DBS to treat tremor using an objective and repeatable acoustic 
protocol. It is also one of only a few studies to incorporate objective 
measures of speech to inform clinical assessment with the aim of 
devising a simple quantifiable platform on which to base clinical 
judgments of speech (Mücke et al., 2014). The use of objective 
acoustic measures allows for quantification of speech changes in 
conjunction with tremor reduction. We have presented six speech 
metrics that were automatically acquired using predesigned scripts 
within a freely available software platform. Pooling variance of 
these measures suggested that all four speech timing measures were 
strongly correlated with speech rate in some patients, but not all. 
For clinicians/researchers seeking an easily interpretable objective 
measure of speech for DBS optimization, the inclusion of speech 
rate (syllables per second), voice quality (HNR), and vocal control 
(f0 coefficient of variation) derived from the counting and sustained 
vowel tasks may provide a simplified but objective solution.
The next step in this line of investigation is to develop a speech 
index that offers the treating clinician a single metric on which to 
base their decisions on speech production, a dysarthria index. The 
benefit of such an index lies in its potential as a clinical tool with 
instant quantitative feedback for the treating clinician.
limitations
The generalizability of these findings needs to be considered in 
the context of several methodological caveats. Data were acquired 
from a small and heterogeneous group of patients. This means 
that the likelihood of observing stimulation-induced dysarthria 
was small given that estimates of speech disturbance in essential 
tremor is around 10% of patients receiving DBS. It appears that 
only one of the six patients produced speech that changed in 
line with tremor response to DBS. Altered speech was observed 
in the remaining five patients to varying degrees. It could be 
argued that those changes, although present, may not be clini-
cally significant, a hypothesis that needs to be tested in a larger 
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cohort of patients with matched listener ratings. Similarly, a wider 
array of acoustic measures could be employed to further capture 
the dysarthria-related changes in production. Candidates could 
include key spectral and cepstral measures of the voice as well as 
more targeted metrics derived from hand selected components of 
speech including slope of second formant transitions as suggested 
by Weismer et al. (2012). It is important to consider how clinically 
useful acoustic measures are that require experts to interpret data 
or time consuming manual analysis. Interpretable data that are 
acquired and analyzed easily and automatically are necessary for 
uptake by clinicians.
conclusion
The changes in speech observed from DBS amplitude variation are 
often subtle in isolation. However, the cumulative effect of speech 
timing, vocal control, and quality deficits can lead to reduced intel-
ligibility and increased dysarthria severity. These side effects can 
potentially diminish the efficacy of DBS as a tool for improving 
quality of life. Here we have shown that quantitative analysis of 
speech can be achieved within the context of evaluating tremor 
outcomes following randomized amplitude variation. We have also 
demonstrated that changes in amplitude of stimulation delivered 
to the PSA can lead to changes in speech but that these changes 
appear to be patient specific and often not present when optimal 
settings for tremor suppression were established. Data also suggest 
that PSTA stimulation may have dissociable effects on speech and 
other motor functions.
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